Home / Contributors
National collaborators (data providers)The list of data providers will be updated after the first call for data.
Who can be a collaborator?
If you have access to information and data relevant to cancer screening programmes in your country and if you manage, monitor, and/or evaluate a cancer screening programme (e.g. as a member of the national cancer screening programme, ministry of health, national cancer institute, health or public health administration, or another academic institution), you may contact our team to become a collaborator to provide data to the CanScreen5 network. The role of the data provider is to collect screening data for the respective country, obtain a mandate from the ministry of health to share the data, submit the data to the CanScreen5 web portal, review the analysed data, and contribute to this project. For further details, please contact us or send an email to firstname.lastname@example.org. Your contribution to the project will be duly acknowledged.
How to provide data and contribute to the CanScreen5 platform:
1. Provide your full contact details (name, organization, address, email, position, etc.) with the contact form
2. Obtain a mandate (from the national/regional authority, regulatory agency, etc.) following the standard procedures, to share the data
3. Access the submission platform (password and link will be provided by the CanScreen5 Secretariat)
4. Complete the data collection forms (qualitative and quantitative tools) to provide and check the data
5. Submit the data to the CanScreen5 platform
6. Respond to any queries after the review of the submitted data by the Secretariat or by the Scientific Committee
7. Review and validate the final data after the review process
Technical supportThe development of the web platform and the transfer of quantitative data for the European Union was facilitated by Mr Mariano Tomatis under the guidance of Dr Antonio Ponti.
Technical advice and templates from the IARC Cancer Today website (maps, charts, and graphs) were provided by Dr Freddie Bray, Mr Frederic Lam, and Mr Morten Ervik (IARC Section of Cancer Surveillance).
The transcription of the qualitative data and the extraction of data for the country profiles were performed by Mr Antoine Kossi Abalo as part of an internship (Université Lyon I).
We gratefully acknowledge the contributions and valuable suggestions made by Dr Karen Müller of the IARC Communications Group.
Financial supportThis project is partly funded by IARC intramural funds and by the European Union Public Health Programme (Scientific and technical support to the European Partnership for Action against Cancer and follow-up of the implementation of the Council Recommendation on Cancer Screening (IARC_SCR) with support from grant agreement No. 2011 5303) for the preparation of the European Cancer Screening Report 2017.
Dr Silvana Luciani from the Pan American Health Organization (PAHO) supported the organization of the meeting to harmonize data collection tools and methodologies for Latin America.
The European Union Joint Research Centre (JRC) in Ispra, Italy, supported the organization of the meeting on the monitoring activities of European cancer screening programmes.
Scientific CommitteeRole of the Scientific Committee:
1. Define the sources of data collection
2. Define the performance indicators
3. Review and adapt the data collection process and tools
4. Define the criteria for valid data and grading of quality
5. Review and validate the data based on the specific criteria before the data are uploaded to the website
6. Review the ethical and regulatory issues related to the project
7. Participate as faculty for the regional training
Members of the Scientific Committee:
Dr Youssef Chami Khazraji, Fondation Lalla Salma - Prévention et traitement des cancers, Rabat, Morocco.
Dr Kumiko Saika, National Cancer Center, Tokyo, Japan.
Dr Suleeporn Sangrajrang, National Cancer Institute, Bangkok, Thailand.
Dr Kacem Zendehdel, Ministry of Health - Iranian National Cancer Control Committee, Tehran, Islamic Republic of Iran.
Dr Eva Kantelhardt, Martin Luther University of Halle-Wittenberg, Halle, Germany.
Dr Françoise Hamers, Coordinatrice Evaluation des dépistages des cancers, Agence nationale de santé publique, Saint-Maurice, France [CHAIR].
Dr Carlo Senore, CPO Piemonte, Italy.
Latin America and the Caribbean:
Dr Marianna de Camargo, National Cancer Institute, INCA, Rio de Janeiro, Brazil.
Dr Catterina Ferreccio, Pontificia Universidad Católica de Chile, Santiago, Chile.
Dr Eduardo Lazcano-Ponce, Instituto Nacional de Salud Pública de México, Fellow: Australian National University.
Dr Mona Saraiya, Centers for Disease Contol and Prevention, Division of Cancer Prevention and Control, Atlanta, USA.
Professor Diana Sarfati, Department of Public Health, University of Otago, Wellington, New Zealand.
International collaboratorsTo be announced soon
IARC management teamRole of the management team:
1. Conceptualize the project
2. Develop and maintain the CanScreen5 website
3. Contact potential collaborators
4. Perform checking and initial validation of data
5. Liaise with the Scientific Committee and process data for review by the members
6. Ensure the quality and accuracy of the data and information
IARC Secretariat (Screening Group):
Dr Partha Basu: Project Principal Investigator
Mr Eric Lucas: Project Coordinator
Dr André Carvalho: Scientist
Dr Catherine Sauvaget: Epidemiologist
Dr Richard Muwonge: Statistician
Ms Loubna Boulegroun: Secretarial support
Ms Krittika Pitaksaringkarn: Layout design and technical support
Advisory boardRole of advisors:
1. Improving the quality and scientific validity of the project
2. Building an effective network and collaboration to sustain the project
3. Preparing the training modules and the training plan
4. Reviewing ethical and regulatory issues to ensure that the data collection and sharing practices remain in line with international ethical standards
5. Reviewing the manuscripts and the reports generated by the project from time to time
6. Other relevant matters
Advisory board members:
Dr Sharon Kapambwe, Department of Health Promotion, Environment and Social Determinants, Ministry of Health, Lusaka, Zambia.
Dr Samar Al-Homoud, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
Dr Ibtihal Fadhil, Eastern Mediterranean NCD Alliance and Global NCD Alliance, Dubai, United Arab Emirates.
Dr Rengaswamy Sankaranarayanan, Visiting Scientist, IARC [CHAIR].
Dr Ahti Anttila, Mass Screening Registry, Finnish Cancer Registry, Helsinki, Finland.
Dr Antonio Ponti, CPO Piemonte, Italy.
Dr Terje Andreas Eikemo, Department of Sociology and Political Science, Norwegian University of Science and Technology (NTNU), Trondheim, Norway.
Latin America and the Caribbean:
Dr Arn Migowski, National Cancer Institute, INCA, Rio de Janeiro, Brazil.
Dr Silvina Arrossi, Centro de Estudios de Estado y Sociedad (CEDES), Buenos Aires, Argentina.
Dr Rolando Herrero, Head, Section of Early Detection and Prevention, Prevention and Implementation Group, IARC.
Dr Silvana Luciani, Pan American Health Organization, Washington DC, USA.
Dr Raúl Murillo, Visiting Scientist, Prevention and Implementation Group, IARC.
Dr Douglas Puricelli Perrin, ICSN Program Coordinator and Support for Global Health Program & Policy Analysis at U.S. National Cancer Institute/Center for Global Health, USA.
Dr Stephen Taplin, Senior Advisor in Cancer Screening, Center for Global Health, National Cancer Institute, USA.
Dr Edward L Trimble, Senior Advisor for Global HPV and Cervical Cancer Research and Control, Office of the Director, National Cancer Institute, NIH, HHS, Rockville, USA.
Professor Linda Rabeneck, Prevention and Cancer Control at Cancer Care Ontario, Dalla Lana School of Public Health at the University of Toronto, Institute for Clinical Evaluative Sciences (ICES), Toronto, Canada.
Professor Karen Canfell, Cancer Research Division, Cancer Council NSW, Woolloomooloo , Australia.